Company news, product registrations, industry insights and events — follow the evolution of the industry with SinoExci.
After 18 months of R&D and filing, our injection-grade SAIB passed CDE review and obtained a registration number — a key breakthrough in high-end excipients for sustained-release injectables.
After 18 months of R&D and filing, our injection-grade SAIB passed CDE review and obtained a registration number — a key breakthrough in high-end excipients for sustained-release injectables.
After 18 months of R&D and filing, our injection-grade SAIB passed CDE review and obtained a registration number — a key breakthrough in high-end excipients for sustained-release injectables.
After 18 months of R&D and filing, our injection-grade SAIB passed CDE review and obtained a registration number — a key breakthrough in high-end excipients for sustained-release injectables.
After 18 months of R&D and filing, our injection-grade SAIB passed CDE review and obtained a registration number — a key breakthrough in high-end excipients for sustained-release injectables.
After 18 months of R&D and filing, our injection-grade SAIB passed CDE review and obtained a registration number — a key breakthrough in high-end excipients for sustained-release injectables.
